Sleep problems and insomnia have become increasingly prevalent in China, especially among the younger population, due to work-related stress, anxiety, and the constant use of digital devices. The onset of the pandemic has exacerbated the problem. Following a relaxation of restrictions in 2021 as virus cases fell, leading to greater mobility outside of the home and a slowing of demand for sleep aids, the resurgence of COVID-19 in early 2022 brought another spike in sleep issues among Chinese cons...
Euromonitor International's Sleep Aids in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Sleep Aids in China
Euromonitor International
September 2022
List Of Contents And Tables
SLEEP AIDS IN CHINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Prevalence of sleep disorders during pandemic-related home seclusion drives sales of sleep aids in 2022
Rising proportion of young consumers suffer from insomnia and poor sleep quality
Updated regulations favour the further development of melatonin in sleep aids
PROSPECTS AND OPPORTUNITIES
Sleep aids to further expand in terms of format and formula innovation to differentiate
Diversifying range of alternative solutions may pose competition to sleep aids
E-commerce likely to gain further share
CATEGORY DATA
Table 1 Sales of Sleep Aids: Value 2017-2022
Table 2 Sales of Sleep Aids: % Value Growth 2017-2022
Table 3 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 4 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 5 Forecast Sales of Sleep Aids: Value 2022-2027
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
CONSUMER HEALTH IN CHINA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources